Zylox-Tonbridge Medical Technology. 

€1.37
0
+€0+0% Tuesday 08:15

统计数据

当日最高
1.39
当日最低
1.37
52周最高
-
52周最低
-
成交量
0
平均成交量
-
市值
448M
市盈率
137
股息收益率
-
股息
-

即将到来

收益

19Aug预期
Q4 2023
Q2 2024
0.03
0.36
0.69
1.03
预期每股收益
N/A
实际每股收益
0.026368274575

人们还关注

此列表基于关注818.F的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

关于

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices the People's Republic of China and internationally. The company develops neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. It also develops peripheral-vascular interventional product portfolio covering a spectrum of arterial and venous products comprising stents, balloons, catheters, and filters, as well as covers hemodialysis access, aortic intervention, peripheral embolization intervention, and radiological intervention products. In addition, the company provides technical consultation and services, as well as imports materials. The company was formerly known as Zhejiang Zylox Medical Device Co., Ltd. and changed its name to Zylox-Tonbridge Medical Technology Co., Ltd. in March 2021. Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Hangzhou, the People's Republic of China.
Show more...
首席执行官
Dr. Zhong Zhao
员工
756
国家
CN
ISIN
CNE100004JD2
WKN
000A3CS7H

上市公司